Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.77 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.41 |
| ▸ | PTPN7 | P35236 | 3/20 | 0.39 |
| ▸ | HMGCR | P04035 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Palmitonitrile SCHEMBL17183997 | 1.00 | TSHR (0.77) | TSHRTHRBALDH1A1TDP1DNM1 | |
| SCHEMBL181303 | 1.00 | TSHR (0.77) | TSHRTHRBALDH1A1TDP1DNM1 | |
| SCHEMBL11095447 | 1.00 | TSHR (0.77) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Octane SCHEMBL6002112 | 1.00 | TSHR (0.77) | TSHRTHRBALDH1A1TDP1DNM1 | |
| SCHEMBL181158 | 1.00 | TSHR (0.77) | TSHRTHRBALDH1A1TDP1DNM1 | |
| SCHEMBL60342 | 1.00 | TSHR (0.77) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Heptane SCHEMBL3240570 | 1.00 | TSHR (0.77) | TSHRTHRBALDH1A1TDP1DNM1 | |
| SCHEMBL345850 | 1.00 | TSHR (0.77) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Octane SCHEMBL20497305 | 1.00 | TSHR (0.77) | TSHRTHRBALDH1A1TDP1DNM1 | |
| SCHEMBL61880 | 1.00 | TSHR (0.77) | TSHRTHRBALDH1A1TDP1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4396306-B1 | A METHOD FOR DECREASING FEED IMPURITIES | NESTE OYJ (FI) | 2025-07-30 | — | — | EP | disclosed |
| US-20240350942-A1 | A METHOD FOR DECREASING FEED IMPURITIES | NESTE OYJ (FI) | 2024-10-24 | — | — | US | disclosed |
| US-20240128511-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-04-18 | — | — | US | disclosed |
| US-11942601-B2 | Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-03-26 | — | — | US | disclosed |
| US-20220336858-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | MITUSBISHI CHEMICAL CORPORATION (JP) | 2022-10-20 | — | — | US | disclosed |
| US-11424482-B2 | Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-08-23 | — | — | US | disclosed |
| CN-110003047-B | Method for preparing nitrile by reacting acetone cyanohydrin with alkyl halide | 哈尔滨理工大学 | 2022-05-06 | — | — | CN | disclosed |
| EP-3463293-B1 | INJECTABLE SOLUTION AT PH 7, COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5, A PRANDIAL INSULIN AND/OR A GASTROINTESTINAL HORMONE, AND A COPOLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS | ADOCIA (FR) | 2021-05-12 | — | — | EP | disclosed |
| EP-3463294-B1 | COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION, COMPRISING HUMAN GLUCAGON AND A STATISTICAL COPOLYAMINO ACID | ADOCIA (FR) | 2020-08-05 | — | — | EP | disclosed |
| EP-3184171-B1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2019-03-20 | — | — | EP | disclosed |
| US-20150299107-A1 | SELECTIVE EXTRACTION OF AN OMEGA-FUNCTIONALIZED ACID AFTER OXIDATIVE CLEAVAGE OF AN UNSATURATED FATTY ACID AND DERIVATIVES | ARKEMA FRANCE (FR) | 2015-10-22 | — | — | US | disclosed |
| US-8927746-B2 | Process for synthesizing omega-functionalized acids from fatty acids or fatty esters | ARKEMA FRANCE (FR) | 2015-01-06 | — | — | US | disclosed |
| US-20140221645-A1 | Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-08-07 | — | — | US | disclosed |
| US-20140148607-A1 | Process for Synthesizing Omega-Functionalized Acids from Fatty Acids or Fatty Esters | ARKEMA FRANCE (FR) | 2014-05-29 | — | — | US | disclosed |
| CN-103814007-A | Process for synthesizing omega-functionalized acids from fatty acids or fatty esters | ARKEMA FRANCE | 2014-05-21 | — | — | CN | disclosed |
| US-8680003-B2 | Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-03-25 | — | — | US | disclosed |
| US-20120309965-A1 | Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2012-12-06 | — | — | US | disclosed |
| EP-2519532-A1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | Chevron Phillips Chemical Company LP (US) | 2012-11-07 | — | — | EP | disclosed |
| WO-2011082192-A1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2011-07-07 | — | — | WO | disclosed |
| US-3936490-A | FROM BUTADIENE AND ACETONITRILE WITH A BASIC ALKALI METAL CONTAINING CATALYST | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309965-A1 | Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins | NIT2, NCLN, NPM1 | TSHR 3542/4885THRB 4680/4885ALDH1A1 4849/4885 |
| US-20140221645-A1 | Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins | NIT2, NCLN, NPM1 | TSHR 3542/4885THRB 4680/4885ALDH1A1 4849/4885 |
| US-20140148607-A1 | Process for Synthesizing Omega-Functionalized Acids from Fatty Acids or Fatty Esters | FASN, FFAR2, FADS1 | TSHR 1324/4885THRB 1688/4885ALDH1A1 965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.